Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

246
Delayed Quote. Delayed BATS EUROPE - 04/24 05:29:59 pm
392.2500 DKK   +0.50%
04/23 For Western companies, Russia's recovery is worth waiting for
04/22 NOVO NORDISK A/ : A/S : - Share repurchase programme
04/22 NOVO NORDISK A/ : A/S : - Reduction of the share capital
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on NOVO NORDISK A/S
04/23 NOVO NORDISK A/S : Share repurchase programme
04/23 NOVO NORDISK A/S : Reduction of the share capital
04/23 For Western companies, Russia's recovery is worth waiting for
04/22 NOVO NORDISK A/S : Patent Issued for Determination of Position of Injection Need..
04/22 NOVO NORDISK A/S : Findings from Novo Nordisk Yields New Data on Rheumatoid Arth..
04/22 NOVO NORDISK A/S : Celebrates World Hemophilia Day and Shares New Support Progra..
04/22 NOVO NORDISK A/S : New Findings Reported from Novo Nordisk Describe Advances in ..
04/22 NOVO NORDISK A/S : A/S : - Share repurchase programme
04/22 NOVO NORDISK A/S : A/S : - Reduction of the share capital
04/21DJU.S. Firms Urge China to Improve Conditions
04/21DJU.S. Firms Urge China to Improve Conditions -- Update
04/20DJU.S. Firms Want China to Improve Business Conditions
04/16 NOVO NORDISK A/S : New Findings on Immunoproteins Described by Investigators at ..
04/13 NOVO NORDISK A/S : Bjarne Graven Larsen appointed CFO of Novo A/S
04/13 NOVO NORDISK A/S : Share repurchase programme
04/13 NOVO NORDISK A/S : A/S : - Share repurchase programme
04/11 NOVO NORDISK A/S : More than 450,000 Ghanaians living with Diabetes
04/10 NOVO NORDISK A/S : -US FDA accepts Tresiba and Ryzodeg resubmissions for review
04/10 NOVO NORDISK A/S : opens new insulin formulation and filling facility in Russia
04/09 NOVO NORDISK A/S : New Study: 1.5 Billion Dollars Could be Saved by Reducing Com..
04/08 NOVO NORDISK A/S : Details Findings in Diabetes (Relationship of Diabetes Compli..
04/08 NOVO NORDISK A/S : Findings from Novo Nordisk in Diabetic Nephropathies Reported..
04/08 NOVO NORDISK A/S : Investigators at Novo Nordisk Describe Findings in Obesity (T..
04/08DJNovo Nordisk's Insulin Drug Application Accepted by FDA
04/07 US FDA accepts Tresiba(R) and Ryzodeg(R) resubmissions for review
04/07 NOVO NORDISK A/S : US FDA accepts Tresiba® and Ryzodeg® resubmissions for review
04/01 NOVO NORDISK A/S : Status regarding Novo Nordisk's holding of its own shares (31..
04/01 NOVO NORDISK A/S : Study Results from Novo Nordisk Provide New Insights into Mon..
04/01 BRISTOL MYERS SQUIBB : Acquires Exclusive License from Novo Nordisk for a Discov..
04/01 NOVO NORDISK A/S : A/S: Status regarding 's holding of its own shares (31 March ..
04/01 NOVO NORDISK A/S : A/S : - Share repurchase programme
04/01 NOVO NORDISK A/S : Share repurchase programme
03/31 EMISPHERE TECHNOLOGIES : Reports Fourth Quarter and Full Year 2014 Financial Res..
03/31 BRISTOL MYERS SQUIBB : Purchases Exclusive License from Novo Nordisk
03/31 EMISPHERE TECHNOLOGIES : Reports Fourth Quarter and Full Year 2014 Financial Res..
03/27DJEUROPE MARKETS : European Stocks Snap Win Streak; DAX Logs First Weekly Loss In ..
03/27DJEUROPE MARKETS : European Stocks Set To Snap String Of Weekly Wins
03/27 NNIT A/S : 14/2015 Major shareholder announcement
03/27DJEUROPE MARKETS : European Stocks Set To Break String Of Weekly Wins
03/27 BRISTOL MYERS SQUIBB : Acquires Exclusive License from Novo Nordisk
03/26 NOVO NORDISK A/S : Novo Nordisk has decided to resubmit the New Drug Application..
03/26 NOVO NORDISK A/S : A/S : has decided to resubmit the New Drug Applications of Tr..
03/26 Zosano Pharma Reports 2014 Financial Results
03/25 NOVO NORDISK A/S : Novo Nordisk completes phase 3a trials comparing faster-actin..
03/25 NOVO NORDISK A/S : A/S: completes phase 3a trials comparing faster-acting insuli..
03/24 Zosano Pharma Reports 2014 Financial Results
03/24 NOVO NORDISK A/S : Saxenda® approved in Europe for the treatment of obesity
03/24 NOVO NORDISK A/S : -Saxenda approved in Europe for the treatment of obesity
03/24DJNOVO NORDISK A/S : Gets EU Marketing Approval for Obesity Treatment
03/23 NOVO NORDISK A/S : Saxenda(r) approved in Europe for the treatment of obesity
03/23 NOVO NORDISK A/S : A/S: Saxenda® approved in Europe for the treatment of obesity
03/23 NOVO NORDISK A/S : A/S : - Share repurchase programme
03/22 NOVO NORDISK A/S : Type 1 diabetes sufferers welcome U.S. team at Tour de Taiwan
03/20 NOVO NORDISK A/S : ex-dividend day for annual dividend
03/19 NOVO NORDISK A/S : Resolutions from the Annual General Meeting of Novo Nordisk A..
03/19 Biodel Updates on Positive Preliminary Results from Study 6-101
03/18 NOVO NORDISK A/S : Data on Type 2 Diabetes Reported by Researchers at Novo Nordi..
03/18 NOVO NORDISK A/S : Type 1 Diabetes - In Search of a Cure
03/18 NOVO NORDISK A/S : BD has 6mn diabetic patients half of them unaware
03/18 NOVO NORDISK A/S : Share repurchase programme
03/17 NOVO NORDISK A/S : Share repurchase programme
03/16 NOVO NORDISK A/S : A/S : - Share repurchase programme
03/12 NOVO NORDISK A/S : Watch and Vote for Video Showing Novo Nordisk’s Approac..
03/11 NOVO NORDISK A/S : Recent Studies from Novo Nordisk Add New Data to Peptidoglyca..
03/11 NOVO NORDISK A/S : An Application for the Trademark "AWONCY" Has Been Filed by N..
03/10 NOVO NORDISK A/S : Named on the 2015 FORTUNE 100 Best Companies to Work For® Lis..
03/09 NOVO NORDISK A/S : NNE Pharmaplan delivers solid result and focuses the business
03/09 NOVO NORDISK A/S : A/S : - Share repurchase programme
03/06 NOVO NORDISK A/S : gennemfører succesfuld børsnotering af NNIT A/S
03/04 NOVO NORDISK A/S : Clear Choices - Briefing
03/04 NOVO NORDISK A/S : Study Results from Novo Nordisk in the Area of Colitis Report..
03/04 NOVO NORDISK A/S : From Denmark to Mozambique: Health on Two Wheels
03/04 NOVO NORDISK A/S : Patent Issued for Insulins with an Acyl Moiety Comprising Rep..
03/04 HYBIO PHARMACEUTICAL : Patent Application Titled "Method for Purifying Solid-Pha..
03/02 NOVO NORDISK A/S : A/S: A/S - Share repurchase programme
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF